Parkinson's Disease Trial, Recruiting NCT05884944 Sponsor: New York Institute of Technology Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05884944
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease by a neurologist, and your condition is rated between 2 and 4 on a standard scale used to measure how severe Parkinson's symptoms are (called the Hoehn and Yahr Scale)
  • You are able to receive a type of hands-on physical treatment that involves gentle manipulation of muscles and joints (called Osteopathic Manipulative Medicine, or OMM)
  • You are able to lie flat on your back and on your stomach for a muscle measurement test
  • You are able to walk, so that your walking pattern can be measured
  • You experience leg pain, leg cramping, or changes in the way you walk because of your Parkinson's disease

Who may not be able to join:

  • You have severe, frequent involuntary muscle twitching (called fasciculations) that could interfere with measurements, based on a doctor's assessment
  • Your walking difficulties are caused by something other than Parkinson's disease
  • You have another diagnosed neurological condition (such as a stroke or multiple sclerosis) that could affect muscle stiffness or your ability to walk, and therefore affect the results of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 516-686-1300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
New York Institute of Technology
Registry
ClinicalTrials.gov
Start date
6 July 2023
Est. completion
1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mechanical stress via the MyotonPro; Dynamic Stiffness via the MyotonPro; Step Cycle time via the Biodex Gait Trainer 3; Average step length via the Biodex Gait Trainer 3; Step Symmetry- time on each foot via the Biodex Gait Trainer 3; Goniometer- Hip ROM (Flexion and Extension); Goniometer- Hip ROM Flexion; Goniometer- Hip ROM Extension; Goniometer- Knee ROM - Flexion; Goniometer- Knee ROM - Extension; Goniometer- Ankle ROM- Dorsiflexion; Goniometer- Ankle ROM- Plantarflexion; The Timed Up & Go- 3 Meter walk

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov